Back to News
Market Impact: 0.4
Charles River Laboratories International Q3 Earnings Call Highlights
Source: marketbeat.com
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
Charles River Laboratories raised its 2026 revenue and earnings outlook after third-quarter organic revenue growth accelerated to 4.7%. Growth was supported by demand for safety assessment and manufacturing testing services.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
CRL0.75
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook